Consejo Superior de Investigaciones Científicas (CSIC);Centro de Investigación Biomédica en Red Enfermedades Raras;Universidad Autónoma De Madrid (UAM)
The present invention relates to a group of compounds with a structural nucleus derived from phenylacetamide, having the following formula (I): that can modulate the DREAM neuronal calcium sensor. Consequently, the present invention also relates to the use of these compounds for the treatment or prevention of disorders or diseases in which DREAM levels are above or below physiologically normal levels.